Considerations in choosing an antidepressant

Psychiatric Services

Volumn 52, Issue 11, 2001, Pages 1435-1436

  Kingsbury, S J ^a   Simpson, G M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; SEXUAL DYSFUNCTION; SHORT SURVEY;

ANTIDEPRESSIVE AGENTS; DECISION MAKING; DEPRESSIVE DISORDER; HUMANS; OVERDOSE; SEROTONIN UPTAKE INHIBITORS;

EID: 0034764172     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.52.11.1435     Document Type: Short Survey

References (2)

1. Interruption of selective serotonin reuptake inhibitor treatment: Double-blind, placebo-controlled trial